患病前的脂质水平和ALS的长期风险 - - 一项基于人口的队列研究
Anders Myhre Vaage1,2, Jūratė Šaltytė Benth2,3, Haakon E Meyer4,5
1Department of Neurology, Akershus University Hospital, Lørenskog, Norway.
Amyotrophic lateral sclerosis & frontotemporal degeneration
|December 20, 2023
概括
高的LDL-C水平预测了几十年后的肌缩性侧面硬化症 (ALS) 风险. 虽然较高的总胆固醇和甘油三也显示了联系,但它们似乎是ALS的后果,而不是预测因素.
科学领域:
- 神经科学是一个神经科学.
- 流行病学 流行病学
- 生物化学 生物化学
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种具有复杂病因的进展性神经退行性疾病.
- 脂质代谢在各种神经疾病中起作用.
- 了解ALS的预发性风险因素对于早期识别和潜在干预至关重要.
研究的目的:
- 调查前病态脂质样本与发展ALS的风险之间的长期时间关系.
- 为了确定特定的脂质生物标志物是否可以作为ALS发展的预测因素.
主要方法:
- 利用挪威心血管健康调查 (1974-2003) 的数据,包括总胆固醇,甘油三,高密度胆固醇-C,低密度胆固醇-C和葡萄糖.
- 从经过验证的挪威卫生登记处,将调查数据与ALS发病率和死亡率联系起来.
- 采用考克斯回归模型来评估患病前脂质水平与ALS风险之间的关联,平均随访时间为23.7年.
主要成果:
- 低密度脂蛋白胆固醇 (LDL-C) 增加1mmol/l与ALS风险增加6%有关.
- 较高的总胆固醇 (TC) 和甘油三 (TG) 与增加ALS风险有关,但主要是在诊断或死亡前6-7年内.
- 在高密度脂蛋白胆固醇 (HDL-C) 和ALS风险之间没有发现显著的关联.
结论:
- 较高的LDL-C水平与ALS风险增加有关,这可能表明长期存在因果关系.
- 观察到的TC和TG的关联表明它们可能是ALS的后果,而不是早期预测因素.
- 这些发现凸显了脂质失调在ALS病变发生中的潜在作用.
更多相关视频
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
7.3K
12:35Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
Published on: March 17, 2012
28.1K
相关概念视频
03:03Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
01:24Overview of Lipid Metabolism
1.6K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.6K
01:15Parkinson's Disease: Overview
554
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
554
01:26Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492